Buserelin
(PYMDEDHDQYLBRT-DRIHCAFSSA-N)
Structure
- SMILES
- CC(=O)O.CCNC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)[C@H](Cc1ccc(cc1)O)NC(=O)[C@@H](NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)CO)COC(C)(C)C)CC(C)C)CCCN=C(N)N
- Molecular Formula:
- C62H90N16O15
- Molecular Weight:
- 1299.480
- Log P:
- 3.2163
- Hydrogen Bond Acceptor:
- 29
- Hydrogen Bond Donor:
- 16
- TPSA:
- 478.07
- CAS Number(s):
- 68630-75-1
Synonym(s)
1.
Buserelin
2.
Bigonist
3.
Buserelin Acetate
4.
HOE-766
5.
Profact
6.
Receptal
7.
Suprecur
8.
Suprefact
9.
Tiloryth
10.
Acetate, Buserelin
11.
HOE 766
12.
HOE766
External Link(s)
| MeSH | D002064 |
| PubChem Compound | 50224 |
| ChEBI | 31324 |
| CHEMBL | CHEMBL2106198 |
| KEGG | cpd:C13301 dr:D01831 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Lymphocyte count decreased | Canada Vigilance: 1 | Canada Vigilance | |
| 2 | Palliative Care | Canada Vigilance: 1 | Canada Vigilance | |
| 3 | Product dose omission | Canada Vigilance: 1 | Canada Vigilance | |
| 4 | Ultrasound uterus abnormal | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120269
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.